GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 786 filers reported holding GLAXOSMITHKLINE PLC in Q3 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $384,000 | +28.9% | 8,772 | +28.2% | 0.02% | +66.7% |
Q1 2022 | $298,000 | +4.2% | 6,843 | +5.5% | 0.01% | +9.1% |
Q4 2021 | $286,000 | +21.7% | 6,489 | +5.4% | 0.01% | 0.0% |
Q3 2021 | $235,000 | -0.8% | 6,159 | +3.5% | 0.01% | 0.0% |
Q2 2021 | $237,000 | +11.3% | 5,949 | +31.2% | 0.01% | -38.9% |
Q4 2019 | $213,000 | +3.9% | 4,533 | -13.5% | 0.02% | -10.0% |
Q1 2018 | $205,000 | – | 5,239 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 325,823 | $11,557,000 | 6.52% |
KAHN BROTHERS GROUP INC | 1,139,163 | $40,406,111,000 | 6.35% |
Chubb Ltd | 400,000 | $14,188,000 | 6.18% |
Healthcare Value Capital, LLC | 50,000 | $1,774,000 | 5.40% |
CLARK ESTATES INC/NY | 650,000 | $23,056,000 | 3.81% |
PVG ASSET MANAGEMENT CORP | 220,450 | $7,819,361,000 | 3.57% |
Martin Capital Partners, LLC | 88,195 | $3,128,000 | 3.25% |
Camber Capital Management LP | 1,500,000 | $53,205,000 | 2.60% |
EQUITY INVESTMENT CORP | 2,090,120 | $74,137,000 | 2.47% |
Keystone Financial Planning, Inc. | 129,102 | $4,579,000 | 2.44% |